FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057483721> ?p ?o ?g. }

• W2057483721 endingPage "574" @default.
• W2057483721 startingPage "567" @default.
• W2057483721 abstract "In an effort to improve the selectivity of the anticancer drug methotrexate (MTX), a series of potential prodrugs in which the 2-amino group was acylated with various alpha-amino acids (as well as L-pyroglutamic acid) was synthesized. Such derivatives are anticipated to be hydrolysed to MTX by appropriate aminopeptidases localized (over-expressed naturally or targeted as anti-tumor antibody conjugates) in the vicinity of the tumor. The L-leucyl, L-valyl, L-isoleucyl, D-alanyl and L-pyroglutamyl derivatives were assessed as to their suitability as prodrugs. Except for the L-pyroglutamyl compound, all derivatives decomposed slowly when incubated in phosphate buffer, pH 7.3; the formation of MTX was minimal. No major differences were observed when serum was included in the incubation medium, except for the L-leucyl compound, which was hydrolysed to MTX. The L-leucyl, L-valyl and L-isoleucyl derivatives were hydrolysed readily to MTX by aminopeptidase M (EC 3.4.11.2), while the L-pyroglutamyl and D-alanyl compounds were activated by pyroglutamate aminopeptidase (EC 3.4.19.3) (from Bacillus amyloliquefaciens) and D-aminopeptidase (from Ochrobactrum anthropi), respectively. When tested for inhibition of the target enzyme dihydrofolate reductase (DHFR; EC 1.5.1.3), 2-L-valyl-MTX showed inhibition two orders of magnitude poorer than that given by MTX, in agreement with the expectation that acylation of the 2-amino group reduces binding to DHFR. After treatment of this derivative with aminopeptidase M, the extent of inhibition correlated with the amount of MTX formed. MTX derivatives alone or in combination with the complementary peptidase were tested for cytotoxicity on murine L1210 cells in culture. The above-listed derivatives were considerably less cytotoxic than MTX, except for the L-leucyl derivative which showed considerable cytotoxicity. When the appropriate exogenous peptidase was included, the cytotoxicity of the activated prodrugs approached that of MTX. These results indicate that 2-L-leucyl-MTX is unsuitable as a prodrug since it is activated prematurely by serum enzymes. Although the L-valyl and L-isoleucyl derivatives do not hydrolyse to MTX in serum and are readily activated, they are not ideal prodrugs since they decompose under physiological conditions; the properties of the decomposition product will have a bearing on the ultimate suitability of these compounds. 2-L-Pyroglutamyl-MTX is the best candidate prodrug, showing stability and ready activation by the appropriate aminopeptidase." @default.
• W2057483721 created "2016-06-24" @default.
• W2057483721 creator A5003164780 @default.
• W2057483721 creator A5044876866 @default.
• W2057483721 creator A5048308517 @default.
• W2057483721 creator A5048510058 @default.
• W2057483721 creator A5066929731 @default.
• W2057483721 creator A5076367246 @default.
• W2057483721 creator A5076825576 @default.
• W2057483721 date "1995-02-01" @default.
• W2057483721 modified "2023-09-23" @default.
• W2057483721 title "Activation and cytotoxicity of 2-α-aminoacyl prodrugs of methotrexate" @default.
• W2057483721 cites W1119893438 @default.
• W2057483721 cites W1211684059 @default.
• W2057483721 cites W133027658 @default.
• W2057483721 cites W1494023132 @default.
• W2057483721 cites W1517588315 @default.
• W2057483721 cites W1573615374 @default.
• W2057483721 cites W1889007409 @default.
• W2057483721 cites W1931176519 @default.
• W2057483721 cites W1968858321 @default.
• W2057483721 cites W1985228353 @default.
• W2057483721 cites W2001731555 @default.
• W2057483721 cites W2010936037 @default.
• W2057483721 cites W2023717765 @default.
• W2057483721 cites W2032843807 @default.
• W2057483721 cites W2036165325 @default.
• W2057483721 cites W2038816888 @default.
• W2057483721 cites W2038842216 @default.
• W2057483721 cites W2044503608 @default.
• W2057483721 cites W2047490075 @default.
• W2057483721 cites W2054256358 @default.
• W2057483721 cites W2056564173 @default.
• W2057483721 cites W2064516026 @default.
• W2057483721 cites W2071786395 @default.
• W2057483721 cites W2071954948 @default.
• W2057483721 cites W2076616258 @default.
• W2057483721 cites W2077021033 @default.
• W2057483721 cites W2125013276 @default.
• W2057483721 cites W2132223750 @default.
• W2057483721 cites W2218903297 @default.
• W2057483721 cites W2409186072 @default.
• W2057483721 cites W2949075511 @default.
• W2057483721 doi "https://doi.org/10.1016/0006-2952(94)00456-v" @default.
• W2057483721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7872963" @default.
• W2057483721 hasPublicationYear "1995" @default.
• W2057483721 type Work @default.
• W2057483721 sameAs 2057483721 @default.
• W2057483721 citedByCount "26" @default.
• W2057483721 countsByYear W20574837212012 @default.
• W2057483721 countsByYear W20574837212013 @default.
• W2057483721 countsByYear W20574837212014 @default.
• W2057483721 countsByYear W20574837212016 @default.
• W2057483721 countsByYear W20574837212021 @default.
• W2057483721 crossrefType "journal-article" @default.
• W2057483721 hasAuthorship W2057483721A5003164780 @default.
• W2057483721 hasAuthorship W2057483721A5044876866 @default.
• W2057483721 hasAuthorship W2057483721A5048308517 @default.
• W2057483721 hasAuthorship W2057483721A5048510058 @default.
• W2057483721 hasAuthorship W2057483721A5066929731 @default.
• W2057483721 hasAuthorship W2057483721A5076367246 @default.
• W2057483721 hasAuthorship W2057483721A5076825576 @default.
• W2057483721 hasConcept C108215921 @default.
• W2057483721 hasConcept C161790260 @default.
• W2057483721 hasConcept C181199279 @default.
• W2057483721 hasConcept C185592680 @default.
• W2057483721 hasConcept C193557335 @default.
• W2057483721 hasConcept C203014093 @default.
• W2057483721 hasConcept C2776580952 @default.
• W2057483721 hasConcept C2780985610 @default.
• W2057483721 hasConcept C2781059491 @default.
• W2057483721 hasConcept C2781320022 @default.
• W2057483721 hasConcept C515207424 @default.
• W2057483721 hasConcept C55493867 @default.
• W2057483721 hasConcept C71240020 @default.
• W2057483721 hasConcept C86803240 @default.
• W2057483721 hasConceptScore W2057483721C108215921 @default.
• W2057483721 hasConceptScore W2057483721C161790260 @default.
• W2057483721 hasConceptScore W2057483721C181199279 @default.
• W2057483721 hasConceptScore W2057483721C185592680 @default.
• W2057483721 hasConceptScore W2057483721C193557335 @default.
• W2057483721 hasConceptScore W2057483721C203014093 @default.
• W2057483721 hasConceptScore W2057483721C2776580952 @default.
• W2057483721 hasConceptScore W2057483721C2780985610 @default.
• W2057483721 hasConceptScore W2057483721C2781059491 @default.
• W2057483721 hasConceptScore W2057483721C2781320022 @default.
• W2057483721 hasConceptScore W2057483721C515207424 @default.
• W2057483721 hasConceptScore W2057483721C55493867 @default.
• W2057483721 hasConceptScore W2057483721C71240020 @default.
• W2057483721 hasConceptScore W2057483721C86803240 @default.
• W2057483721 hasIssue "4" @default.
• W2057483721 hasLocation W20574837211 @default.
• W2057483721 hasLocation W20574837212 @default.
• W2057483721 hasOpenAccess W2057483721 @default.
• W2057483721 hasPrimaryLocation W20574837211 @default.
• W2057483721 hasRelatedWork W1675997988 @default.
• W2057483721 hasRelatedWork W2017854085 @default.
• W2057483721 hasRelatedWork W2044628742 @default.

• next